CN110133253A - Broad spectrum type antigen-antibody protective agent - Google Patents

Broad spectrum type antigen-antibody protective agent Download PDF

Info

Publication number
CN110133253A
CN110133253A CN201910396961.1A CN201910396961A CN110133253A CN 110133253 A CN110133253 A CN 110133253A CN 201910396961 A CN201910396961 A CN 201910396961A CN 110133253 A CN110133253 A CN 110133253A
Authority
CN
China
Prior art keywords
protective agent
antigen
antibody
broad spectrum
spectrum type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910396961.1A
Other languages
Chinese (zh)
Inventor
程梦楠
徐媛媛
李圆莉
叶小飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Saitang Biotechnology Co Ltd
Original Assignee
Shanghai Saitang Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Saitang Biotechnology Co Ltd filed Critical Shanghai Saitang Biotechnology Co Ltd
Priority to CN201910396961.1A priority Critical patent/CN110133253A/en
Publication of CN110133253A publication Critical patent/CN110133253A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention proposes a kind of broad spectrum type antigen-antibody protective agent, the antigen-antibody protective agent be in PBS dilution containing 2% bovine serum albumin(BSA) (BSA), 0.05% polysorbas20,25% glycerol, 0.02% NaN3.Broad spectrum type antigen-antibody protective agent provided by the invention can protect antigen-antibody activity the long period compared with other two kinds of protective agents (BSA protective agent, disaccharide protective agent), especially be able to maintain activity in room temperature and 37 DEG C.

Description

Broad spectrum type antigen-antibody protective agent
Technical field
The present invention relates to field of biotechnology more particularly to broad spectrum type antigen-antibody protective agents.
Background technique
Enzyme-linked immunosorbent assay enzyme linked immunosorbent assay (writing a Chinese character in simplified form ELISA) refer to by Soluble antigen or antibody is integrated on the solid phase carriers such as polystyrene, is carried out using antigen-antibody binding specificity immune anti- The qualitative and quantitative detecting method answered.
ELISA tests the activity for predominantly detecting antigen-antibody, and having complete antigen-antibody activity is to antigen in sample The content of antibody carries out the necessary factor of accurately quantitative and qualitative detection.
Under normal circumstances, antigen-antibody can be because the variation of condition be easy to inactivate, and the antigen for causing sample to be surveyed is anti- The content of body is lower than actual content.
Our company improves existing protective agent and finds preferred plan, can protect antigen-antibody activity the long period, especially exist Room temperature and 37 DEG C are able to maintain activity.
Summary of the invention
The purpose of the present invention is to provide a kind of broad spectrum type antigen-antibody protective agents, the long period can protect antigen-antibody Activity.
To achieve the above object, the technical scheme adopted by the invention is as follows: a kind of broad spectrum type antigen-antibody protective agent, this is anti- Original antibody protective agent is to contain 2% bovine serum albumin(BSA), 0.05% polysorbas20 in PBS dilution.
It further, further include 25% glycerol, 0.02% NaN3 in the antigen-antibody protective agent.
Utilize application of the broad spectrum type antigen-antibody protective agent in protection antigen-antibody activity.
And active protection is carried out to antigen-antibody under 4 DEG C, room temperature and 37 DEG C of environment using antigen-antibody protective agent.
It should be pointed out that the broad spectrum type antigen-antibody protective agent being made of bovine serum albumin(BSA), glycerol and tween, uses Special ratios, relative to simple bovine serum albumin(BSA) or glycerol or other any two kinds of combinations, effect is all good, also, its Protecting effect is also superior to common disaccharide protective agent effect.
Detailed description of the invention
Fig. 1 be 37 DEG C at each protective agent to antigen preservation effect curve.
Fig. 2 is preservation effect curve of each protective agent to antigen at room temperature.
Fig. 3 be at 4 DEG C each protective agent to the preservation effect curve of antigen.
Specific embodiment
The technical solution adopted in the present invention is further described below in conjunction with schematic diagram.
Embodiment 1: a kind of broad spectrum type antigen-antibody protective agent, the antigen-antibody protective agent are in PBS dilution containing 2% Bovine serum albumin(BSA) (BSA), 0.05% polysorbas20, which uses as BSA protective agent.
The configuration method of antigenic dilution are as follows: with PBS dissolution BSA and dilution polysorbas20, making content is respectively 2% He 0.05%.
PBS dilution has no special requirements, conventional PBS dilution.
Embodiment 2: a kind of broad spectrum type antigen-antibody protective agent, the antigen-antibody protective agent are in PBS dilution containing 2% Bovine serum albumin(BSA) (BSA), 0.05% polysorbas20,25% glycerol, 0.02% NaN3, the antigen-antibody protective agent conduct Broad spectrum type protective agent uses.
The protectant configuration method of broad spectrum type are as follows: PBS dilution contains BSA (2%), glycerol (25%), polysorbas20 (0.05%), NaN3 (0.02%).
It is given below disaccharide protective agent to be carried out to above-described embodiment referring to comparison, the disaccharide protective agent is as a kind of common Type antigen-antibody protective agent contains sucrose and trehalose for PBS dilution, and sucrose is adopted with content of trehalose in the disaccharide protective agent With three kinds of schemes:
Scheme one [30% sugared protective agent]: the sucrose and trehalose dissolved in disaccharide protective agent with PBS makes sucrose and seaweed Sugared content is 30%.
Scheme two [10% sugared protective agent]: the sucrose and trehalose dissolved in disaccharide protective agent with PBS makes sucrose and seaweed Sugared content is 10%.
Scheme three [5% sugared protective agent]: the sucrose and trehalose dissolved in disaccharide protective agent with PBS makes sucrose and seaweed Sugared content is 5%.
Broad spectrum type protective agent and 30% disaccharide protective agent (previously mentioned scheme one) are in room temperature and 37 DEG C of energy digital preservations Antigen-antibody activity, antigen active ELISA detection display, in 37 DEG C of addition antigen-antibody protective agents, (30% sugared protective agent is wide Spectral pattern protective agent) antigen active remained unchanged substantially from 0-10 weeks.In contrast, add BSA protective agent and low sugar protective agent The antigen active conspicuousness of (10% sugar and 5% sugar) reduces, and referring to Fig. 1, which is that each protective agent imitates antigen preservation at 37 DEG C Fruit curve graph.
Various protective agents are similar with 37 DEG C to the active protecting effect of antigen at room temperature, i.e., added with protective agent (30% disaccharide Protective agent and broad spectrum type protective agent) antigen active from 0-5 weeks, there was no significant difference, but added with BSA protective agent and added with low sugar Protectant antigenicity is substantially reduced, referring to fig. 2, the figure be at room temperature each protective agent to the preservation effect curve graph of antigen.
Three kinds of protective agents are prepared by our company, in different temperatures and time showing protection difference (table 1).At 37 DEG C, with 30% Sugared protective agent and the protectant two kinds of store method effects of broad spectrum type are good.In previous scheme, the guarantor of single sugar is utilized Shield agent type is less, and content is low, and best active protection percentage also only reaches 80% or so.Such as be applied alone 10% trehalose or 10% sucrose can all make that the active protection percentage of antigen is low and the holding time is shorter, and best also only saves 60 hours.
1 three kinds of protective agents of table are to antigen active protection relative percentage
Preservation condition BSA protective agent 30% sugared protective agent Broad spectrum type protective agent 10% sugared protective agent 5% sugared protective agent
0 week, 37 DEG C 100% 100% 100% 100% 100%
1 week, 37 DEG C 52% 118% 127% 108% 58%
3 weeks, 37 DEG C 2% 104% 91% 2% 1%
5 weeks, 37 DEG C 4% 103% 122%
10 weeks, 37 DEG C 0% 73% 99%
0 week, room temperature 100% 100% 100% 100% 100%
1 week, room temperature 64% 108% 100% 117% 89%
3 weeks, room temperature 4% 126% 95% 18% 6%
5 weeks, room temperature 0% 86% 119%
The lower three kinds of protective agents effect of low temperature condition there is not significant difference, but high sugar can inhibit ELISA test result (referring to figure 3)。
Three of the above antigen-antibody protective agent (BSA protective agent, broad spectrum type protective agent, disaccharide protection are compared in ELISA test Agent), broad spectrum type protective agent is suitable for most of antigen-antibody at 4 DEG C as the result is shown, room temperature and 37 DEG C of one month or more activity, It is more more stable than common carbohydrate protective agent and BSA protective agent protecting effect lasting, and ELISA testing result is not interfered.
It should be pointed out that antigen saves the configuration method of liquid are as follows: by antigen protein antigen-antibody protective agent above-mentioned Dilution is miscible, is utilized high concentration antigen configuration antigen to save liquid as far as possible according to condition, using preceding further according to needing to dilute.
Certainly, synantigen can not try out different antigen-antibody protective agents first, to obtain best protection effect, and wide spectrum Type protective agent is applicable in various antigens and various temperature (low temperature, room temperature are to 37 DEG C), and part specific antigen or should not contain glycerol Antigenic solution can try out under 30% disaccharide protective agent (i.e. above-mentioned scheme one) or low temperature select BSA protective agent replace Generation.
The above is only a preferred embodiment of the present invention, does not play the role of any restrictions to the present invention.Belonging to any Those skilled in the art, in the range of not departing from technical solution of the present invention, to the invention discloses technical solution and Technology contents make the variation such as any type of equivalent replacement or modification, belong to the content without departing from technical solution of the present invention, still Within belonging to the scope of protection of the present invention.

Claims (4)

1. a kind of broad spectrum type antigen-antibody protective agent, which is characterized in that the antigen-antibody protective agent is to contain 2% in PBS dilution Bovine serum albumin(BSA), 0.05% polysorbas20.
2. broad spectrum type antigen-antibody protective agent according to claim 1, which is characterized in that in the antigen-antibody protective agent also Including 25% glycerol, 0.02% NaN3.
3. a kind of broad spectrum type antigen-antibody protective agent as described in claim 1-2 is any answering in protection antigen-antibody activity With.
4. application according to claim 3, which is characterized in that using antigen-antibody protective agent in 4 DEG C, room temperature and 37 DEG C Active protection is carried out to antigen-antibody under environment.
CN201910396961.1A 2019-05-14 2019-05-14 Broad spectrum type antigen-antibody protective agent Pending CN110133253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910396961.1A CN110133253A (en) 2019-05-14 2019-05-14 Broad spectrum type antigen-antibody protective agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910396961.1A CN110133253A (en) 2019-05-14 2019-05-14 Broad spectrum type antigen-antibody protective agent

Publications (1)

Publication Number Publication Date
CN110133253A true CN110133253A (en) 2019-08-16

Family

ID=67573562

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910396961.1A Pending CN110133253A (en) 2019-05-14 2019-05-14 Broad spectrum type antigen-antibody protective agent

Country Status (1)

Country Link
CN (1) CN110133253A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1409758A (en) * 1999-12-14 2003-04-09 热生物之星公司 Stabilizing diluent for polypeptides and antigens
CN101118238A (en) * 2007-08-29 2008-02-06 浙江大学 Composite protecting agent and uses thereof
CN105628914A (en) * 2016-02-04 2016-06-01 广州科方生物技术有限公司 Diluent enabling stability for acridinium ester antigen-antibody conjugate and preparation method of diluent
CN107449918A (en) * 2017-08-01 2017-12-08 中山和芯生物技术有限公司 A kind of protein chip stabilizer and its preparation method and application
CN108484756A (en) * 2018-04-28 2018-09-04 河北鑫辉生物科技有限公司 A kind of antibody preserves liquid and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1409758A (en) * 1999-12-14 2003-04-09 热生物之星公司 Stabilizing diluent for polypeptides and antigens
CN101118238A (en) * 2007-08-29 2008-02-06 浙江大学 Composite protecting agent and uses thereof
CN105628914A (en) * 2016-02-04 2016-06-01 广州科方生物技术有限公司 Diluent enabling stability for acridinium ester antigen-antibody conjugate and preparation method of diluent
CN107449918A (en) * 2017-08-01 2017-12-08 中山和芯生物技术有限公司 A kind of protein chip stabilizer and its preparation method and application
CN108484756A (en) * 2018-04-28 2018-09-04 河北鑫辉生物科技有限公司 A kind of antibody preserves liquid and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
江涛等: "弓形虫病ELISA诊断抗原保存方法的研究", 《长江大学学报(自然科学版)》, vol. 5, no. 2, pages 42 - 45 *

Similar Documents

Publication Publication Date Title
Pizarro-Guajardo et al. Ultrastructural variability of the exosporium layer of Clostridium difficile spores
Basha et al. The identity of proteins associated with a small heat shock protein during heat stress in vivo indicates that these chaperones protect a wide range of cellular functions
Moriyama et al. H+-translocating ATPase in Golgi apparatus: Characterization as vacuolar H+-ATPase and its subunit structures
US20110236412A1 (en) Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
Lee et al. In vitro autolysis of plant cell walls
Hong et al. Combined product and substrate inhibition equation for cellobiase
US20110212127A1 (en) Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
CN107449918A (en) A kind of protein chip stabilizer and its preparation method and application
CN103063830B (en) A kind of preparation method of ELISA pre-coated elisa plate
CN103134931A (en) Double antibody sandwich method of detecting staphylococcus aureus enterotoxin A of food
Maruyama et al. Periductal induction of high endothelial venule-like vessels in type 1 autoimmune pancreatitis
CN108267579A (en) Stablize and preserve dilution, antinuclear antibody detection reagent and its preparation method and application
CN110133253A (en) Broad spectrum type antigen-antibody protective agent
CN108414336B (en) Diluent for improving stability of antigen and antibody
CN102866248A (en) Stabilizer solution and preparation method thereof, enzyme conjugate mixture and protein mixture
Omidfar et al. Stabilization of penicillinase-hapten conjugate for enzyme immunoassay
CN116508744B (en) Sample preservation solution for detecting novel coronavirus antigen and preparation method thereof
Abuknesha et al. Efficient labelling of antibodies with horseradish peroxidase using cyanuric chloride
EP2031390B1 (en) Stabilizing agent and blocking agent
CN103048448B (en) Stationary liquid
Cuppoletti et al. Cytochalasin B binding to Ehrlich ascites tumor cells and its relationship to glucose carrier
JP4505281B2 (en) Stabilizer and blocking agent
CN104530226A (en) Dilute protective agent for horseradish peroxidase-labeled antibody and preparation method thereof
Yazdani et al. Preliminary assessment of various additives on the specific reactivity of anti-rhbsag monoclonal antibodies
CN104611319A (en) Method for improving thermal stability of liquid fructosaminase

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination